Group D | Group E (male subjects only) | |
Number (male) | 7 (7) | 5 (3) |
Age (years) | 54.4 ± 8.4 | 51.6 ± 2.8 (50.0 ± 4.9) |
BMI (kg/m2) | 28.9 ± 2.6 | 30.1 ± 2.1 (29.7 ± 2.3) |
Body fat percentage (%) | 27.8 ± 5.9 | 32.8 ± 9.0 (31.3 ± 7.1) |
Body muscle percentage (%) | 28.2 ± 2.6 | 24.4 ± 7.0 (25.6 ± 5.5) |
75% PWC (Watt) | 104.6 ± 37.2 | 121.8 ± 50.5 (153.7 ± 19.2 ) |
Physical activity level (Mets∙h/week) | 28.8 ± 12.8 | 21.1 ± 12.3 (27.4 ± 6.9) |
Daily calorie intake (kcal/kg/day) | 34.9 ± 5.8 | 30.3 ± 6.8 ( 28.8 ± 8.1) |
Daily protein intake (g/kg/day) | 1.23 ± 0.25 | 1.34 ± 0.32 (1.23 ± 0.35) |
Daily salt intake (g/day) | 10.4 ± 2.8 | 8.8 ± 3.3 (8.3 ± 2.4) |
GFR (mL/min/1.73 m2) | 80.1 ± 38.5 | 76.9 ± 26.1 (75.8 ± 16.6) |
eGFRcre (mL/min/1.73 m2) | 59.3 ± 26.9 | 64.2 ± 24.5 (63.8 ± 15.7) |
Diabetes present | 1 | 2 |
Hypertension present | 7 | 4 |
Anti-RAS drug | 7 | 4 |
Calcium channel blocker | 4 | 3 |
Other type of antihypertensive drug | 4 | 3 |
CKD classification | G1A3, G2A1, G2A2, G2A3, G3aA2, G3bA3, G4A3 | G1A2, G1A3, G2A2, G3aA2, G3aA3 |